XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Intangible Assets and Goodwill
3 Months Ended
Mar. 31, 2020
Intangible Assets and Goodwill  
Intangible Assets and Goodwill

Note 4 – Intangible Assets and Goodwill

Intangible assets consist of the following at:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$'s in 000's

 

 

 

 

 

Useful Lives

 

 

 

March 31, 2020

 

December 31, 2019

Amortizable intangibles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certification

 

 

 

 

 

7 years

 

 

 

$

350

 

$

350

Customer relationships

 

 

 

 

 

12-20 years

 

 

 

 

89,170

 

 

89,232

Patents and processes

 

 

 

 

 

5-10 years

 

 

 

 

4,828

 

 

4,928

Brand names

 

 

 

 

 

5-15 years

 

 

 

 

14,971

 

 

15,019

Total amortizable intangibles

 

 

 

 

 

 

 

 

 

 

109,319

 

 

109,529

Less accumulated amortization

 

 

 

 

 

 

 

 

 

 

(15,184)

 

 

(13,058)

Total net amortizable intangibles

 

 

 

 

 

 

 

 

 

 

94,135

 

 

96,471

Non-amortizable intangibles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks and other

 

 

 

 

 

 

 

 

 

 

18,016

 

 

18,016

In-process research and development

 

 

 

 

 

 

 

 

 

 

5,470

 

 

5,469

Intangible assets, net of accumulated amortization

 

 

 

 

 

 

 

 

 

$

117,621

 

$

119,956

 

Certain intangible assets are denominated in currencies other than the U.S. Dollar; therefore, their gross and net carrying values are subject to foreign currency movements. Amortization expense for the three months ended March 31, 2020 and 2019 was $2.2 million and $1.3 million, respectively.

The in-process research and development (“IPRD”), intangible assets represent the value assigned to acquired R&D projects that principally represent rights to develop and sell a product that the Company has acquired which have not yet been completed or approved. The IPRD acquired as part of the Perrigo Animal Health Acquisition is accounted for as an indefinite-lived asset until the product is available for sale and regulatory approval is obtained, or abandonment of the associated research and development efforts. If the research and development efforts are successfully completed, the IPRD would be amortized over its then estimated useful life. The fair value of the IPRD was estimated using the multi-period excess earnings income method. The projected cash flows estimates for the future products were based on certain key assumptions including estimates of future revenues and expenses, taking into account the stage of development at the acquisition date and the resources needed to complete development.

Estimated future amortization expense for each of the following years is as follows:

 

 

 

 

 

 

 

 

Years ending December 31,  ($'s in 000's)

 

 

 

 

 

 

Remainder of 2020

 

 

 

 

$

6,708

2021

 

 

 

 

 

8,941

2022

 

 

 

 

 

9,154

2023

 

 

 

 

 

8,796

2024

 

 

 

 

 

6,788

Thereafter

 

 

 

 

 

53,748

 

The following is a summary of the changes in the carrying value of goodwill for the period from January 1, 2019 to March 31,  2020:

 

 

 

 

 

 

 

 

 

 

 

 

Reporting Unit

 

 

 

($'s in 000's)

 

Products

 

Services

 

Total

Goodwill as of January 1, 2019

 

 

77,765

 

 

47,264

 

 

125,029

Foreign currency translation

 

 

178

 

 

 —

 

 

178

Acquisitions

 

 

105,838

 

 

 —

 

 

105,838

Goodwill as of December 31, 2019

 

 

183,781

 

 

47,264

 

 

231,045

Foreign currency translation

 

 

(343)

 

 

 —

 

 

(343)

Goodwill as of March 31, 2020

 

$

183,438

 

$

47,264

 

$

230,702